• No results found

inputs for the asset or liability that are not based on observable market data.

In document Science is a matter of connections. (Page 111-113)

(27) Financial instruments FINANCIAL RISK MANAGEMENT

Level 3: inputs for the asset or liability that are not based on observable market data.

The following tables show the movement of fair values at level 3 for the financial years 2014 and 2013, respectively:

For the fair value of the contingent consideration, reasonably possible alternative assumptions of significant unobservable inputs

would have ceteris paribus the following effects as at 31 December 2014 and 2013:

2014 2013

Profit and loss Profit and loss

T€ Increase Decrease Increase Decrease

Contingent consideration

Discount rate (movement of 0.15 %-points) 273 (278) 200 (203)

Commercialisation success rate (movement of 10%-points) 294 (294) 685 (685)

Pension liability at beginning of the year 164 122 Included in other comprehensive income:

Previously not recognised actuarial gains

and losses using the corridor method - 43

Actuarial gains from:

— Changes in financial assumptions 47 (5)

— Experience adjustments - (1)

Included in net income:

Interest cost 5 5

Pension liability at year end 216 164

Year ended Year ended

31 December 31 December

T€ 2014 2013

In the financial years 2014 and 2013, no reclasses were made among the individual levels.

(30) Pension plan

The Company operates a defined contribution Group Personal Pension Plan (GPPP) and makes contributions to employees’ own schemes. The pension charge for the year represents contributions payable by the Company to the fund (and to employees’ own pension schemes) and amounted to T€ 1,150 (2013: T€ 978). Contributions amounting to T€ 112 (2013: T€ 80) were payable to the fund at the year end 2014 and are included in provisions. The Company’s contribution rate is employee specific and is determined by the level of an employee’s contribution. There were no changes in the basis for such contributions during the year. The statutory retirement insurances are defined as contribution plan under IAS 19, but are not included in the amounts stated above.

Further the Company has a 401K in the US the contribution to this plan amounted to T€ 65 during 2014 (2013: T€ 60).

The Company operates a defined benefit pension plan for one former member of the Management Board of Evotec AG. The provision for this pension is calculated using the projected unit credit method in accordance with IAS 19. An actuarial report was prepared in 2014 and 2013 for this purpose. The calculations are based on assumed pension increases of 2.0% and a discount rate of 1.6% in 2014 and 3.2% in 2013. The discount rate reflects market conditions. The provision amounted to T€ 216 and T€ 164 as of 31 December 2014 and 2013, respectively.

The pension obligation developed as follows:

(31) Commitments and contingencies

(a) OPERATING LEASE OBLIGATIONS

The Company leases office and laboratory space and other equipment under operating leases in accordance with IAS 17. The longest of these obligations extends to 2024. Certain leases contain rent increases, rent holidays and renewal options. The total rents due under these leases are recognised on a straight-line basis over the lease term. The future minimum lease payments under non-cancellable operating leases are approximately as follows:

The majority of operating lease obligations are related to rent expenses for facilities. The rent expense for such leases amounted to T€ 4,359 and T€ 4,377 for the years ended 31 December 2014 and 2013, respectively.

(b) OTHER COMMITMENTS AND CONTINGENCIES

The Company has entered into consultancy contracts. During 2014 and 2013, expenses under consultancy contracts totalled T€ 46 and T€ 214, respectively. The future minimum payments associated with long-term consultant and other miscellaneous long-term commitments total approximately T€ 5,404 and T€ 3,874 at 31 December 2014 and 2013, respectively. The significant portion thereof related to long-term commitments in connection with facility expenses.

As of 31 December 2014 and 2013, the Company has entered into purchase commitments in the amount of T€ 1,816 and T€ 657, respectively.

The Company has, in the sale and purchase agreement for all the shares in Evotec Technologies GmbH, provided certain guarantees customary for such agreements. No current liabilities from this guarantee exist as of 31 December 2014 and 2013, respectively.

less than one year 4,905 4,365

between one and five years 17,814 15,654

more than five years 17,738 17,097

Total 40,457 37,116

31 Dec 31 Dec

The Company has licensed or acquired certain third party intellectual property for use in its business. Under these agreements, the Company is required to pay milestones, dependent on development progress and/or royalties and milestones dependent on present and future net income or on sublicensing fees received from third parties. The Company also agreed with several third parties on getting access to their technology and know-how for use in Evotecs business or within collaborations. Under those agreements, the Company is required to pay a revenue share to those third parties. Having resolved the BaFin’s summary proceedings in 2014, the Company is not aware of any material litigation as of 31 December 2014.

(32) Related party transactions

According to IAS 24 the Company discloses related party transactions where Supervisory Board members and Management Team members of the Company hold positions in other entities that result in them having significant influence over the financial or operating policies of these entities (the figures reflect the total group).

In a simultaneous transaction to the direct placement capital increase on 31 August 2013, Biotechnology Value Fund, L.P. and other affiliates of the US biotech specialist investment firm, BVF Partners L.P. also purchased an option from the Company’s shareholder TVM V Life ScienceVentures GmbH & Co. KG granting BVF the right to acquire an additional 11,818,612 shares of Evotec at € 4.00 per share within the next 30 months. 50% of the options provided by TVM to BVF are subject to an option granted by ROI Verwaltungsgesellschaft mbH to TVM with similar conditions as in the option agreement between BVF and TVM. The then members of the supervisory board Roland Oetker and Hubert Birner abstained from the final consultation and vote of the Supervisory Board on the approval of the capital increase to avoid any potential conflict of interest or potential vulnerability of the decision taken, although Roland Oetker and Hubert Birner did not consider themselves as conflicted in regard to these transactions.

Evotec AG recorded revenues in the amount of T€ 0 and T€ 0 with related parties in 2014 and 2013, respectively. Subsidiaries of Evotec AG recorded revenues with related parties in the amount of T€ 2,108 and T€ 0 in 2014 and 2013, respectively. There has been no further material transactions with related parties.

Administrative services provided by the Company to Management Board or Supervisory Board members for their private purposes, if any are reimbursed to the Company at cost.

(33) Personnel expenses

In document Science is a matter of connections. (Page 111-113)